Table of Contents
- Overview
- Results
- Risks
- Prevention
17-hydroxyprogesterone; Progesterone - 17-OH
What the risks are
Veins and arteries vary in size from one patient to another and from one side of the body to the other. Obtaining a blood sample from some people may be more difficult than from others.
Other risks may include:
- Excessive bleeding
- Fainting or feeling light-headed
- Hematoma (blood accumulating under the skin)
- Infection (a slight risk any time the skin is broken)
Special considerations
Your doctor may suggest an
Previous Section
Review Date: 05/31/2011
Reviewed By: Linda Vorvick, MD, Medical Director, MEDEX Northwest Division of
Physician Assistant Studies, University of Washington School of
Medicine; and Susan Storck, MD, FACOG, Chief, Eastside Department
of Obstetrics and Gynecology, Group Health Cooperative of Puget
Sound, Bellevue, Washington; Clinical Teaching Faculty, Department
of Obstetrics and Gynecology, University of Washington School of
Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director,
A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)
